Related Experiment Video
Updated: May 19, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients
Paula Freitas1, Davide Carvalho, Ana Cristina Santos
1Department of Endocrinology, Hospital de São João and University of Porto Medical School, Porto, Portugal. paula_freitas@sapo.pt
Insights
Hypertension risk in HIV patients with lipodystrophy is debated. This study found hypertension is linked to central fat accumulation, not just lipodystrophy, in HIV-infected adults on antiretroviral therapy.
Area of Science:
- Cardiology
- Infectious Diseases
- Endocrinology
Background:
- Hypertension risk in human immunodeficiency virus (HIV)-infected patients, especially those with lipodystrophy, remains unclear.
- Combination antiretroviral therapy (cART) is standard for HIV management but can influence body composition and metabolic health.
- Lipodystrophy, a condition characterized by abnormal fat distribution, is a known complication of cART.
Purpose of the Study:
- To assess the impact of lipodystrophy on hypertension prevalence in HIV-infected adults on cART.
- To investigate the association between specific fat distribution patterns and hypertension.
- To identify body composition factors associated with hypertension in this population.
Main Methods:
- Cross-sectional study of 368 HIV-infected adults receiving cART.
- Lipodystrophy assessed clinically and by fat mass ratio (FMR).
- Body composition evaluated using dual-energy x-ray absorptiometry and computed tomography; blood pressure measured.
Main Results:
- Overall hypertension prevalence was similar in patients with and without clinically or FMR-defined lipodystrophy.
- Patients with isolated central fat accumulation and mixed lipodystrophy showed a significantly higher hypertension prevalence.
- Hypertensive patients had higher total, central, and central/peripheral fat mass ratios.
- Adjusted analysis confirmed hypertension significantly associated with central/peripheral fat mass ratio (OR, 1.258; 95% CI, 1.008-1.569).
Conclusions:
- Hypertension is not more prevalent in HIV patients with lipodystrophy overall.
- Central fat accumulation and mixed lipodystrophy patterns are significantly associated with higher hypertension risk.
- Central/peripheral fat mass ratio is an independent predictor of hypertension in HIV-infected adults on cART.
Abstract:
The data on the risk of hypertension in human immunodeficiency virus (HIV)-infected patients, particularly in those with lipodystrophy, are controversial. The authors assessed the impact of lipodystrophy on hypertension in a cohort of HIV-infected adults receiving combination antiretroviral therapy. This was a cross-sectional study in which lipodystrophy (clinically and fat mass ratio [FMR]-defined), blood pressure, and body composition (dual-energy x-ray absorptiometry and computed tomography) were evaluated in 368 HIV adults. The prevalence of hypertension in HIV patients with or without clinically or FMR-defined lipodystrophy was similar (with clinical lipodystrophy 35.3% vs without 32.9%, not significant; with FMR lipodystrophy 41.7% vs without 32.2%, not significant). When HIV-infected patients were classified into 4 categories of fat distribution (based on the presence or absence of lipoatrophy and abdominal prominence), isolated lipoatrophy was not significantly associated with hypertension, but patients with isolated central fat accumulation and mixed forms of lipodystrophy had a significantly higher prevalence of hypertension. Hypertensive HIV patients had significantly higher total fat, central, and central/peripheral fat mass ratio than normotensive ones. After adjustment for age, sex, smoking, and body mass index, hypertension remains significantly associated with central/peripheral fat mass ratio (odds ratio, 1.258; 95% confidence interval, 1.008-1.569). Hypertension was not more prevalent in lipodystrophic HIV-infected patients, but was significantly associated with central/peripheral fat mass ratio.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Hypertension II: Pathophysiology
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Factors affecting Blood pressure
Physiological Factors:

